Conjugates useful in the treatment of prostate cancer
    6.
    发明授权
    Conjugates useful in the treatment of prostate cancer 失效
    用于治疗前列腺癌的共轭物

    公开(公告)号:US06174858B1

    公开(公告)日:2001-01-16

    申请号:US09193365

    申请日:1998-11-17

    IPC分类号: A61K3800

    摘要: Chemical conjugates which comprise oligopeptides, having amino acid sequences that are selectively proteolytically cleaved by free prostate specific antigen (PSA) and known cytotoxic agents are disclosed. The conjugates of the invention are characterized by attachment of the cleavable oligopeptide to the oxygen atom at the 4-position on a vinca drug that has be desacetylated. Such conjugates are useful in the treatment of prostatic cancer and benign prostatic hypertrophy (BPH).

    摘要翻译: 公开了包含具有由游离前列腺特异性抗原(PSA)和已知的细胞毒性剂选择性蛋白水解切割的氨基酸序列的寡肽的化学共轭物。 本发明的缀合物的特征在于将可切割的寡肽与已经脱乙酰化的长春花药物的4-位上的氧原子连接。 这种缀合物可用于治疗前列腺癌和良性前列腺肥大(BPH)。